nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyltestosterone—CYP3A4—Temozolomide—brain cancer	0.174	0.486	CbGbCtD
Methyltestosterone—CYP3A4—Lomustine—brain cancer	0.148	0.414	CbGbCtD
Methyltestosterone—SLC22A8—choroid plexus—brain cancer	0.0645	0.336	CbGeAlD
Methyltestosterone—Azoospermia—Procarbazine—brain cancer	0.0495	0.128	CcSEcCtD
Methyltestosterone—Oligospermia—Hydroxyurea—brain cancer	0.0493	0.128	CcSEcCtD
Methyltestosterone—Azoospermia—Hydroxyurea—brain cancer	0.0383	0.0994	CcSEcCtD
Methyltestosterone—CYP3A4—Etoposide—brain cancer	0.0358	0.1	CbGbCtD
Methyltestosterone—Clotting—Temozolomide—brain cancer	0.0226	0.0585	CcSEcCtD
Methyltestosterone—Amenorrhoea—Procarbazine—brain cancer	0.0152	0.0394	CcSEcCtD
Methyltestosterone—Gynaecomastia—Procarbazine—brain cancer	0.0119	0.0309	CcSEcCtD
Methyltestosterone—Amenorrhoea—Hydroxyurea—brain cancer	0.0117	0.0305	CcSEcCtD
Methyltestosterone—SHBG—hindbrain—brain cancer	0.0113	0.0586	CbGeAlD
Methyltestosterone—Haemoglobin—Lomustine—brain cancer	0.0106	0.0275	CcSEcCtD
Methyltestosterone—Haemorrhage—Lomustine—brain cancer	0.0105	0.0274	CcSEcCtD
Methyltestosterone—Coagulopathy—Temozolomide—brain cancer	0.0104	0.0269	CcSEcCtD
Methyltestosterone—Alopecia—Lomustine—brain cancer	0.00932	0.0242	CcSEcCtD
Methyltestosterone—Amenorrhoea—Temozolomide—brain cancer	0.00918	0.0238	CcSEcCtD
Methyltestosterone—Trilostane—ESR2—brain cancer	0.00783	0.33	CrCbGaD
Methyltestosterone—Gynaecomastia—Carmustine—brain cancer	0.00747	0.0194	CcSEcCtD
Methyltestosterone—Haemoglobin—Procarbazine—brain cancer	0.00673	0.0175	CcSEcCtD
Methyltestosterone—Haemorrhage—Procarbazine—brain cancer	0.0067	0.0174	CcSEcCtD
Methyltestosterone—SHBG—brainstem—brain cancer	0.00645	0.0336	CbGeAlD
Methyltestosterone—Mestranol—CYP2C9—brain cancer	0.00615	0.259	CrCbGaD
Methyltestosterone—Alopecia—Procarbazine—brain cancer	0.00592	0.0153	CcSEcCtD
Methyltestosterone—Haemoglobin—Hydroxyurea—brain cancer	0.00521	0.0135	CcSEcCtD
Methyltestosterone—Haemorrhage—Hydroxyurea—brain cancer	0.00518	0.0134	CcSEcCtD
Methyltestosterone—Anxiety—Procarbazine—brain cancer	0.00495	0.0128	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Etoposide—brain cancer	0.00484	0.0125	CcSEcCtD
Methyltestosterone—SHBG—gonad—brain cancer	0.00478	0.0249	CbGeAlD
Methyltestosterone—SLCO1A2—telencephalon—brain cancer	0.00475	0.0248	CbGeAlD
Methyltestosterone—Angiopathy—Hydroxyurea—brain cancer	0.0047	0.0122	CcSEcCtD
Methyltestosterone—SHBG—pituitary gland—brain cancer	0.00466	0.0243	CbGeAlD
Methyltestosterone—Alopecia—Hydroxyurea—brain cancer	0.00458	0.0119	CcSEcCtD
Methyltestosterone—Nausea—Lomustine—brain cancer	0.00445	0.0115	CcSEcCtD
Methyltestosterone—Paraesthesia—Procarbazine—brain cancer	0.00427	0.0111	CcSEcCtD
Methyltestosterone—Haemoglobin—Carmustine—brain cancer	0.00421	0.0109	CcSEcCtD
Methyltestosterone—Haemorrhage—Carmustine—brain cancer	0.00419	0.0109	CcSEcCtD
Methyltestosterone—AR—telencephalon—brain cancer	0.00411	0.0214	CbGeAlD
Methyltestosterone—Haemoglobin—Temozolomide—brain cancer	0.00407	0.0106	CcSEcCtD
Methyltestosterone—Haemorrhage—Temozolomide—brain cancer	0.00405	0.0105	CcSEcCtD
Methyltestosterone—CYP19A1—gonad—brain cancer	0.00387	0.0202	CbGeAlD
Methyltestosterone—SLCO1A2—medulla oblongata—brain cancer	0.00374	0.0195	CbGeAlD
Methyltestosterone—Ethinyl Estradiol—ESR2—brain cancer	0.00373	0.157	CrCbGaD
Methyltestosterone—Alopecia—Carmustine—brain cancer	0.0037	0.0096	CcSEcCtD
Methyltestosterone—Angiopathy—Temozolomide—brain cancer	0.00367	0.00953	CcSEcCtD
Methyltestosterone—SHBG—endocrine gland—brain cancer	0.00361	0.0188	CbGeAlD
Methyltestosterone—Alopecia—Temozolomide—brain cancer	0.00358	0.00928	CcSEcCtD
Methyltestosterone—AR—gonad—brain cancer	0.00343	0.0179	CbGeAlD
Methyltestosterone—SLCO1A2—midbrain—brain cancer	0.00341	0.0178	CbGeAlD
Methyltestosterone—AR—pituitary gland—brain cancer	0.00334	0.0174	CbGeAlD
Methyltestosterone—SLCO1A2—spinal cord—brain cancer	0.00333	0.0173	CbGeAlD
Methyltestosterone—SHBG—central nervous system—brain cancer	0.00325	0.0169	CbGeAlD
Methyltestosterone—SHBG—cerebellum—brain cancer	0.00318	0.0166	CbGeAlD
Methyltestosterone—Anxiety—Carmustine—brain cancer	0.00309	0.00802	CcSEcCtD
Methyltestosterone—SLCO1A2—endocrine gland—brain cancer	0.003	0.0156	CbGeAlD
Methyltestosterone—Anxiety—Temozolomide—brain cancer	0.00299	0.00775	CcSEcCtD
Methyltestosterone—Headache—Procarbazine—brain cancer	0.00298	0.00773	CcSEcCtD
Methyltestosterone—SLCO1A2—head—brain cancer	0.00296	0.0154	CbGeAlD
Methyltestosterone—Angiopathy—Etoposide—brain cancer	0.00294	0.00762	CcSEcCtD
Methyltestosterone—CYP19A1—endocrine gland—brain cancer	0.00293	0.0152	CbGeAlD
Methyltestosterone—CYP19A1—head—brain cancer	0.00289	0.015	CbGeAlD
Methyltestosterone—AR—spinal cord—brain cancer	0.00288	0.015	CbGeAlD
Methyltestosterone—Anaphylactic shock—Temozolomide—brain cancer	0.00288	0.00746	CcSEcCtD
Methyltestosterone—Alopecia—Etoposide—brain cancer	0.00286	0.00742	CcSEcCtD
Methyltestosterone—Medroxyprogesterone Acetate—CYP2C9—brain cancer	0.00284	0.12	CrCbGaD
Methyltestosterone—Nausea—Procarbazine—brain cancer	0.00283	0.00733	CcSEcCtD
Methyltestosterone—SLC22A8—head—brain cancer	0.00283	0.0147	CbGeAlD
Methyltestosterone—SLCO1A2—central nervous system—brain cancer	0.0027	0.0141	CbGeAlD
Methyltestosterone—Paraesthesia—Carmustine—brain cancer	0.00267	0.00693	CcSEcCtD
Methyltestosterone—SLCO1A2—cerebellum—brain cancer	0.00264	0.0138	CbGeAlD
Methyltestosterone—CYP19A1—central nervous system—brain cancer	0.00264	0.0137	CbGeAlD
Methyltestosterone—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00263	0.0647	CbGpPWpGaD
Methyltestosterone—AR—endocrine gland—brain cancer	0.00259	0.0135	CbGeAlD
Methyltestosterone—Paraesthesia—Temozolomide—brain cancer	0.00258	0.0067	CcSEcCtD
Methyltestosterone—SHBG—brain—brain cancer	0.00258	0.0134	CbGeAlD
Methyltestosterone—SLC22A8—central nervous system—brain cancer	0.00258	0.0134	CbGeAlD
Methyltestosterone—AR—head—brain cancer	0.00256	0.0133	CbGeAlD
Methyltestosterone—CYP2B6—gonad—brain cancer	0.00249	0.0129	CbGeAlD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—KDM4C—brain cancer	0.00236	0.0581	CbGpPWpGaD
Methyltestosterone—AR—central nervous system—brain cancer	0.00233	0.0122	CbGeAlD
Methyltestosterone—Headache—Hydroxyurea—brain cancer	0.00231	0.00598	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Etoposide—brain cancer	0.0023	0.00597	CcSEcCtD
Methyltestosterone—Nausea—Hydroxyurea—brain cancer	0.00219	0.00567	CcSEcCtD
Methyltestosterone—SLCO1A2—brain—brain cancer	0.00215	0.0112	CbGeAlD
Methyltestosterone—ALB—brain—brain cancer	0.00213	0.0111	CbGeAlD
Methyltestosterone—CYP19A1—brain—brain cancer	0.00209	0.0109	CbGeAlD
Methyltestosterone—Paraesthesia—Etoposide—brain cancer	0.00207	0.00536	CcSEcCtD
Methyltestosterone—SLC22A8—brain—brain cancer	0.00205	0.0107	CbGeAlD
Methyltestosterone—CYP2B6—endocrine gland—brain cancer	0.00188	0.00979	CbGeAlD
Methyltestosterone—Headache—Carmustine—brain cancer	0.00187	0.00484	CcSEcCtD
Methyltestosterone—CYP2B6—head—brain cancer	0.00186	0.00966	CbGeAlD
Methyltestosterone—AR—brain—brain cancer	0.00185	0.00965	CbGeAlD
Methyltestosterone—Headache—Temozolomide—brain cancer	0.0018	0.00467	CcSEcCtD
Methyltestosterone—Nausea—Carmustine—brain cancer	0.00177	0.00459	CcSEcCtD
Methyltestosterone—Nausea—Temozolomide—brain cancer	0.00171	0.00443	CcSEcCtD
Methyltestosterone—CYP2B6—central nervous system—brain cancer	0.00169	0.00882	CbGeAlD
Methyltestosterone—Progesterone—CYP2C9—brain cancer	0.00164	0.0691	CrCbGaD
Methyltestosterone—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.00163	0.0401	CbGpPWpGaD
Methyltestosterone—Testosterone—CYP2C9—brain cancer	0.00155	0.0654	CrCbGaD
Methyltestosterone—Headache—Etoposide—brain cancer	0.00144	0.00374	CcSEcCtD
Methyltestosterone—CYP3A4—endocrine gland—brain cancer	0.00142	0.00739	CbGeAlD
Methyltestosterone—Nausea—Etoposide—brain cancer	0.00137	0.00355	CcSEcCtD
Methyltestosterone—CYP2B6—brain—brain cancer	0.00134	0.007	CbGeAlD
Methyltestosterone—CYP3A4—central nervous system—brain cancer	0.00128	0.00666	CbGeAlD
Methyltestosterone—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00112	0.0275	CbGpPWpGaD
Methyltestosterone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00107	0.0262	CbGpPWpGaD
Methyltestosterone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00105	0.0259	CbGpPWpGaD
Methyltestosterone—CYP19A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00104	0.0256	CbGpPWpGaD
Methyltestosterone—AR—Notch-mediated HES/HEY network—HEY1—brain cancer	0.00103	0.0254	CbGpPWpGaD
Methyltestosterone—AR—FOXA1 transcription factor network—SHH—brain cancer	0.000908	0.0223	CbGpPWpGaD
Methyltestosterone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000855	0.021	CbGpPWpGaD
Methyltestosterone—AR—Nuclear Receptors—ESR2—brain cancer	0.000817	0.0201	CbGpPWpGaD
Methyltestosterone—CYP19A1—Ovarian Infertility Genes—ESR2—brain cancer	0.000806	0.0198	CbGpPWpGaD
Methyltestosterone—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000741	0.0182	CbGpPWpGaD
Methyltestosterone—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000713	0.0175	CbGpPWpGaD
Methyltestosterone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000677	0.0167	CbGpPWpGaD
Methyltestosterone—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000668	0.0164	CbGpPWpGaD
Methyltestosterone—AR—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000645	0.0159	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—HES5—brain cancer	0.00062	0.0153	CbGpPWpGaD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—CDK6—brain cancer	0.000591	0.0145	CbGpPWpGaD
Methyltestosterone—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000549	0.0135	CbGpPWpGaD
Methyltestosterone—AR—Notch-mediated HES/HEY network—HES1—brain cancer	0.000535	0.0132	CbGpPWpGaD
Methyltestosterone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000509	0.0125	CbGpPWpGaD
Methyltestosterone—AR—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000504	0.0124	CbGpPWpGaD
Methyltestosterone—CYP19A1—Ovarian Infertility Genes—CDK4—brain cancer	0.000491	0.0121	CbGpPWpGaD
Methyltestosterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000485	0.0119	CbGpPWpGaD
Methyltestosterone—CYP19A1—Biological oxidations—CYP2C9—brain cancer	0.000454	0.0112	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000448	0.011	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—SIRT1—brain cancer	0.000333	0.00819	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—CCNE1—brain cancer	0.000329	0.00809	CbGpPWpGaD
Methyltestosterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000308	0.00757	CbGpPWpGaD
Methyltestosterone—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000304	0.00747	CbGpPWpGaD
Methyltestosterone—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000292	0.00717	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000288	0.00708	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.00028	0.0069	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000271	0.00668	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000266	0.00654	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000264	0.00649	CbGpPWpGaD
Methyltestosterone—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000261	0.00643	CbGpPWpGaD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—CDKN2A—brain cancer	0.00026	0.00641	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—brain cancer	0.000258	0.00635	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000253	0.00622	CbGpPWpGaD
Methyltestosterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000249	0.00614	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—S100A10—brain cancer	0.000249	0.00613	CbGpPWpGaD
Methyltestosterone—AR—Notch-mediated HES/HEY network—STAT3—brain cancer	0.000234	0.00576	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	0.000233	0.00573	CbGpPWpGaD
Methyltestosterone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000232	0.0057	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000224	0.00552	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000222	0.00547	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000221	0.00545	CbGpPWpGaD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—CCND1—brain cancer	0.00022	0.00541	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000218	0.00537	CbGpPWpGaD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—CTNNB1—brain cancer	0.000218	0.00536	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—brain cancer	0.00021	0.00516	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—HES1—brain cancer	0.000205	0.00504	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000193	0.00475	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000191	0.00471	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—SOD2—brain cancer	0.000189	0.00466	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000188	0.00462	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—RELA—brain cancer	0.000185	0.00456	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000184	0.00453	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000181	0.00445	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000178	0.00439	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—brain cancer	0.000177	0.00436	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—brain cancer	0.000175	0.00431	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000174	0.00429	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000166	0.00408	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000165	0.00406	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—CCND1—brain cancer	0.000163	0.004	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—CTNNB1—brain cancer	0.000161	0.00396	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000158	0.00389	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—SOD2—brain cancer	0.00015	0.0037	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	0.000142	0.00349	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000142	0.00349	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000141	0.00347	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000141	0.00346	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—STAT3—brain cancer	0.00014	0.00345	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000137	0.00336	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—RELA—brain cancer	0.000134	0.00331	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000132	0.00326	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000131	0.00322	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—MPL—brain cancer	0.00013	0.00321	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000129	0.00317	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—EGFR—brain cancer	0.000128	0.00314	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000127	0.00314	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—S100A10—brain cancer	0.000125	0.00307	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000115	0.00283	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000112	0.00275	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—ESR2—brain cancer	0.000111	0.00274	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—RELA—brain cancer	0.000109	0.00269	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	0.000108	0.00266	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000107	0.00262	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—NOTCH2—brain cancer	0.000106	0.0026	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000105	0.0026	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000103	0.00253	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000102	0.00252	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	9.99e-05	0.00246	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—IL2—brain cancer	9.85e-05	0.00242	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.42e-05	0.00232	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	9.29e-05	0.00228	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—brain cancer	9.16e-05	0.00226	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	9.08e-05	0.00223	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—VEGFA—brain cancer	9.05e-05	0.00223	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	8.83e-05	0.00217	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—BSG—brain cancer	8.8e-05	0.00217	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	8.74e-05	0.00215	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—RELA—brain cancer	8.69e-05	0.00214	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CYP2C9—brain cancer	8.59e-05	0.00211	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—MYC—brain cancer	8.54e-05	0.0021	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	8.39e-05	0.00206	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—EGFR—brain cancer	8.36e-05	0.00206	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	7.99e-05	0.00197	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CYP2C9—brain cancer	7.76e-05	0.00191	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	7.69e-05	0.00189	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—MYC—brain cancer	7.35e-05	0.00181	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—BSG—brain cancer	7.3e-05	0.0018	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—brain cancer	7.19e-05	0.00177	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—VEGFA—brain cancer	7.18e-05	0.00177	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	7.08e-05	0.00174	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—TP53—brain cancer	7.02e-05	0.00173	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	6.92e-05	0.0017	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.89e-05	0.0017	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	6.84e-05	0.00168	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—BSG—brain cancer	6.6e-05	0.00162	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—TP53—brain cancer	6.33e-05	0.00156	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—IDH1—brain cancer	6.28e-05	0.00155	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—TP53—brain cancer	6.04e-05	0.00149	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—DNMT1—brain cancer	5.98e-05	0.00147	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	5.81e-05	0.00143	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TRPC6—brain cancer	5.77e-05	0.00142	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—IDH1—brain cancer	5.68e-05	0.0014	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—ESR2—brain cancer	5.37e-05	0.00132	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	5.33e-05	0.00131	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.11e-05	0.00126	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—NOTCH2—brain cancer	5.08e-05	0.00125	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	4.99e-05	0.00123	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP2C9—brain cancer	4.99e-05	0.00123	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—ENO2—brain cancer	4.97e-05	0.00122	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.62e-05	0.00114	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ENO2—brain cancer	4.49e-05	0.0011	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—VAV1—brain cancer	4.32e-05	0.00106	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—SIRT1—brain cancer	4.32e-05	0.00106	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—BSG—brain cancer	4.24e-05	0.00104	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP2C9—brain cancer	4.2e-05	0.00103	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	3.75e-05	0.000922	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—IDH1—brain cancer	3.65e-05	0.000897	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—BSG—brain cancer	3.57e-05	0.000878	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—MYC—brain cancer	3.52e-05	0.000865	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	3.18e-05	0.000784	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—IDH1—brain cancer	3.07e-05	0.000755	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ENO2—brain cancer	2.88e-05	0.000709	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PIK3CG—brain cancer	2.74e-05	0.000675	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.5e-05	0.000615	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ENO2—brain cancer	2.43e-05	0.000597	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PIK3CG—brain cancer	2.28e-05	0.00056	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP2C9—brain cancer	2.27e-05	0.000558	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PIK3CG—brain cancer	2.06e-05	0.000507	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IL2—brain cancer	1.93e-05	0.000475	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—BSG—brain cancer	1.93e-05	0.000474	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—MYC—brain cancer	1.69e-05	0.000417	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—IDH1—brain cancer	1.66e-05	0.000408	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—VEGFA—brain cancer	1.64e-05	0.000404	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PIK3CG—brain cancer	1.32e-05	0.000325	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ENO2—brain cancer	1.31e-05	0.000322	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TP53—brain cancer	1.24e-05	0.000305	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PIK3CG—brain cancer	1.11e-05	0.000274	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PIK3CG—brain cancer	6.01e-06	0.000148	CbGpPWpGaD
